生命科学资讯

10X Genomics Q4 prelim revenue beats on consumables unit strength - TradingView — Track All Markets

Lonza Group AG (VTX:LONN) surges 3.4%; individual investors who own 52% shares profited along with institutions - simplywall.st

Lonza Group AG (VTX:LONN) surges 3.4%; individual investors who own 52% shares profited along with institutions - simplywall.st

Eikon, a high-profile startup led by Merck vets, seeks an IPO

Linking complex microbial interactions and dysbiosis through a disordered Lotka–Volterra model

A geometric shape regularity effect in the human brain

Overexpression of Ssd1 and calorie restriction extend yeast replicative lifespan by preventing deleterious age-dependent iron uptake

Dilated cardiomyopathy-associated RNA-binding motif protein 20 regulates long pre-mRNAs in neurons

Predicting the effect of CRISPR-Cas9-based epigenome editing

Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance

Lipid balance and chemoresistance in cancer cells

10x Genomics (TXG) Achieves Remarkable Progress Despite Economic Challenges - GuruFocus

10x Genomics reports preliminary Q4 revenue $166M, consensus $155.95M - TipRanks

Signal Pulse Poll: What's the mood going into JPM?

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results - PR Newswire

Private and public biotechs go on $4.9B funding spree ahead of JPM

Biotech's 2026 outlook: Six questions for the year ahead

Mirador raises $250M, with plans to become an immunology powerhouse

Genentech CEO says pharmacy benefit manager shift will save $70M

Oregon Public Employees Retirement Fund Buys 7,896 Shares of Agilent Technologies, Inc. $A - MarketBeat